Developer docs
API playgroundTry for free, no card

Search company profiles

Haier Biomedical

Full company profile

uuid02lyrv6

Namestring
Haier Biomedical
Legal namestring
Haier Biomedical
Company typeenum
Public
Founded yearint
2005
Descriptiontext

Haier Biomedical is a Chinese biomedical cold chain equipment manufacturer and subsidiary of Haier Group, founded in 2005 and listed on the Shanghai Stock Exchange STAR Market (stock code 688139) since 2019. The company builds the full temperature range of cold storage equipment from -196°C cryogenic liquid nitrogen containers through -150°C cryogenic freezers, -80°C ultra-low temperature (ULT) freezers, -40°C to -20°C biomedical freezers, blood bank and pharmacy refrigerators (2-8°C), plus transport coolers, centrifuges, biosafety cabinets, sterilization equipment, CO2 incubators, and consumables. It has 10,000+ employees, 795 patents including 114 software copyrights, manufacturing capacity centered on a Qingdao industrial park (with Phase II expansion commenced in 2023), and a global footprint across 135+ countries served through 700+ distribution partners with regional headquarters in the UK, training centers in Dubai, Singapore, and Nigeria, and country-level general managers in Italy and India.

The company's core technology platform combines hydrocarbon and Stirling refrigeration with IoT connectivity, RFID tracking, and a big-data cloud layer. Five integrated U-Network solutions — U-Biobank, U-Vaccine, U-Reagent, U-Blood, and U-Laboratory — connect hardware to real-time monitoring, smart alarms, BIMS-based sample location recognition, and traceability from collection through clinical use. It has obtained the broadest relevant certification stack in its category (WHO PQS, CE, UL, Energy Star, NSF, TÜV SÜD, ATEX, NMPA, MDR, FDA for LN2 management in 2024, ISO 9001/14001, CNAS lab accreditation, and CTSOA airworthiness) and participates in 32 national and industry standards.

Revenue is generated through three streams: hardware sales of cold storage and laboratory equipment, subscription-based IoT/digital scenario solutions, and after-sales installation, maintenance, and technical services. GTM combines direct enterprise field sales with channel partners, targeting hospitals, universities and research institutions, government health authorities, bio-pharmaceutical enterprises, blood stations, and CDCs. Marquee customers include PLA 301 Hospital, Wuxi Apptec, Hengrui Pharmaceutical, Fosun Pharmaceutical, Hualan Biological, NUS, University of Sydney, King's College London, NIHR Sheffield, the Uzbekistan and Cameroon Ministries of Health, and WHO/UNICEF CCEOP procurement programs. Pricing is enterprise quote-based on multi-year contracts; no public pricing is disclosed.

Short descriptiontext

Haier Biomedical manufactures IoT-enabled biomedical cold chain equipment spanning -196°C to +8°C, serving hospitals, research institutions, government health agencies, and bio-pharmaceutical companies across 135+ countries through 700+ distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersQingdao Shi, China
HQ citystring
Qingdao Shi
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical cold chain, ultra-low temperature freezers, cryogenic storage equipment, IoT laboratory solutions, vaccine cold chain
Industry1 code
1Cold Chain & Temperature-Controlled Storage Equipment
CodeIMAHAKAJPrimaryYes
NAICS code5 codes
  • Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing33341
  • Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use334512
  • Analytical Laboratory Instrument Manufacturing334516
  • Refrigerated Warehousing and Storage493120
  • Medical Equipment and Supplies Manufacturing3391
SIC code4 codes
  • Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip3585
  • Refrigeration & Service Industry Machinery3580
  • Laboratory Analytical Instruments3826
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Biomedical Cold Chain Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Cold Storage Equipment Sales
TypeHardware Sales
Description

Sale of low-temperature storage equipment including ULT freezers, pharmacy refrigerators, blood bank refrigerators, cryogenics, transport coolers, and laboratory equipment covering -196°C to +8°C range.

haiermedical.com
2Digital IoT Solutions
TypeSubscription Recurring
Description

IoT-enabled digital scenario solutions including U-Biobank, U-Vaccine, U-Reagent, U-Blood, and U-Laboratory networks providing comprehensive management platforms with monitoring, tracking, and automation capabilities.

haiermedical.com
3After-sales Service
TypeProfessional Services
Description

After-sales support, maintenance, installation services, and technical support for equipment across global markets.

haiermedical.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise equipment sales - no public pricing available
ModelOtherBilling cadenceMulti-year contract
Notes

Products sold directly to enterprises, hospitals, and institutions through sales representatives and distribution network. No consumer-facing pricing listed on website.

haiermedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1U-Biobank Network
Description

IoT-based biobank solution platform combining cryogenic storage and IoT management system for biological sample management

haiermedical.com
+6 more records
Core offering1 text field

Haier Biomedical manufactures and sells comprehensive cold chain equipment covering -196°C to +8°C for biomedical and life science applications, including ultra-low temperature freezers, pharmacy refrigerators, blood bank refrigerators, cryogenic liquid nitrogen storage, transport coolers, centrifuges, and laboratory equipment. The product portfolio is extended by IoT-enabled digital scenario solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) that connect hardware to cloud platforms for real-time monitoring, sample tracking, and automated management. Target customers include hospitals, bio-pharmaceutical enterprises, universities, research institutions, government health agencies, and blood stations globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Access time reduced from one minute to one second with IoT biobank management
+3 more records
Product overview1 text field

Haier Biomedical is a comprehensive cold chain manufacturer covering temperatures from -196°C to +8°C. The company offers a unified portfolio of products organized into Cold Storage (ULT Freezers, Pharmacy Refrigerators, Biomedical Freezers, Cryogenics, Transport Coolers), Cell Culture Solutions (CO2 Incubators, Biological Safety Cabinets, Clean Benches, Sterilization), Centrifugation equipment, Pharmacy solutions (Refrigerators, RFID Systems, Intelligent Automation), Blood Management products, Healthcare/Medical equipment, Sample Preparation tools, and Analytical Instruments. The portfolio is complemented by five IoT network solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) that connect hardware products to cloud platforms for real-time monitoring and data management. The product ecosystem spans from standalone equipment to integrated smart solutions, addressing hospitals, biobanks, pharmaceutical enterprises, research institutions, and public health organizations globally.

Product and service1 record
1ULT Freezers (-80°C)
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-07-17
Description

Partnership announced in Australia for providing cold chain solutions supporting Abcellera's biotech research and development operations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing partnership for global health initiatives. Haier Biomedical led in WHO contract awards for Chinese suppliers and participates in WHO projects including vaccine cold chain programs in multiple countries.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for global immunization programs through CCEOP (Cold Chain Equipment Optimization Platform) projects. Has supplied vaccine refrigerators to countries under UNICEF tenders.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joined UNGC Global Initiative, committing to sustainable development principles.

540+ International Organizations
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnerships with over 40 international organizations for global health initiatives, including organizations beyond WHO and UNICEF for various healthcare and research programs.

haiermedical.com
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global life sciences tools leader with broad ULT freezer, lab equipment, and cold chain offerings (e.g., Thermo Scientific TSX, HERAfreeze). Direct overlap with Haier Biomedical in ULT freezers, pharmacy refrigeration, and CO2 incubators, but as part of a much wider instruments and consumables portfolio.

TypeBroad incumbent
Description

Global HVAC and commercial refrigeration leader. Overlaps with Haier in cold room/walk-in refrigeration and commercial cooling equipment for medical warehouses, though as part of a broader industrial HVAC portfolio.

TypeDirect peer
Description

Japan-based PHCbi brand is one of the most direct competitors to Haier Biomedical, specializing in ULT freezers, pharmacy refrigerators, and biomedical cold storage for pharma and life sciences. Competes head-to-head across the same -80°C to +8°C temperature range.

TypeBroad incumbent
Description

Life sciences tools and reagents company with adjacent lab consumables, sample preparation, and GMP-grade proteins. Comparable customer base of pharma, biotech, and academic researchers, though not a direct cold chain competitor.

TypeBroad incumbent
Description

Swedish-listed specialist in refrigeration solutions for medical, transport, and hospitality segments. Comparable in transport coolers and mobile medical refrigeration, though with broader non-biomedical focus.

TypeDirect peer
Description

US-based specialist in blood bank refrigerators, plasma freezers, and pharmacy refrigeration. Closely comparable to Haier's Blood Management product line serving hospitals and blood centers with temperature-controlled medical storage.

TypeDirect peer
Description

Luxembourg-based specialist in vaccine cold chain (Solar Direct Drive refrigerators, ice-lined units) and blood bank refrigeration. Direct peer in WHO PQS-certified vaccine storage solutions and a frequent competitor for UNICEF/CCEOP tenders.

TypeEmerging player
Description

US-based specialist in Stirling-engine ULT freezers offering portable and energy-efficient -86°C storage. Competes in the same ULT freezer category as Haier's UltraEco and Stirling Compact ULT lines, particularly on energy efficiency.

TypeDirect peer
Description

Danish manufacturer of ultra-low temperature freezers, laboratory freezers, and biomedical cold storage. Comparable specialty focus on biomedical ULT and blood bank refrigeration, competing for the same European and global research/hospital customers.

TypeDirect peer
Description

German manufacturer of laboratory equipment including ULT freezers (CryoCube), centrifuges, CO2 incubators, and consumables. Highly comparable product portfolio targeting the same hospital, pharma, and academic research customers as Haier Biomedical.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance16 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Haier Biomedical

Biomedical Cold Chain Equipmenthaiermedical.com

Haier Biomedical manufactures IoT-enabled biomedical cold chain equipment spanning -196°C to +8°C, serving hospitals, research institutions, government health agencies, and bio-pharmaceutical companies across 135+ countries through 700+ distributors.

What Haier Biomedical does

Haier Biomedical is a Chinese biomedical cold chain equipment manufacturer and subsidiary of Haier Group, founded in 2005 and listed on the Shanghai Stock Exchange STAR Market (stock code 688139) since 2019. The company builds the full temperature range of cold storage equipment from -196°C cryogenic liquid nitrogen containers through -150°C cryogenic freezers, -80°C ultra-low temperature (ULT) freezers, -40°C to -20°C biomedical freezers, blood bank and pharmacy refrigerators (2-8°C), plus transport coolers, centrifuges, biosafety cabinets, sterilization equipment, CO2 incubators, and consumables. It has 10,000+ employees, 795 patents including 114 software copyrights, manufacturing capacity centered on a Qingdao industrial park (with Phase II expansion commenced in 2023), and a global footprint across 135+ countries served through 700+ distribution partners with regional headquarters in the UK, training centers in Dubai, Singapore, and Nigeria, and country-level general managers in Italy and India.

The company's core technology platform combines hydrocarbon and Stirling refrigeration with IoT connectivity, RFID tracking, and a big-data cloud layer. Five integrated U-Network solutions — U-Biobank, U-Vaccine, U-Reagent, U-Blood, and U-Laboratory — connect hardware to real-time monitoring, smart alarms, BIMS-based sample location recognition, and traceability from collection through clinical use. It has obtained the broadest relevant certification stack in its category (WHO PQS, CE, UL, Energy Star, NSF, TÜV SÜD, ATEX, NMPA, MDR, FDA for LN2 management in 2024, ISO 9001/14001, CNAS lab accreditation, and CTSOA airworthiness) and participates in 32 national and industry standards.

Revenue is generated through three streams: hardware sales of cold storage and laboratory equipment, subscription-based IoT/digital scenario solutions, and after-sales installation, maintenance, and technical services. GTM combines direct enterprise field sales with channel partners, targeting hospitals, universities and research institutions, government health authorities, bio-pharmaceutical enterprises, blood stations, and CDCs. Marquee customers include PLA 301 Hospital, Wuxi Apptec, Hengrui Pharmaceutical, Fosun Pharmaceutical, Hualan Biological, NUS, University of Sydney, King's College London, NIHR Sheffield, the Uzbekistan and Cameroon Ministries of Health, and WHO/UNICEF CCEOP procurement programs. Pricing is enterprise quote-based on multi-year contracts; no public pricing is disclosed.

Haier Biomedical firmographics

Firmographics
Name
Haier Biomedical
Legal name
Haier Biomedical
Website
https://haiermedical.com
Company type
Public
Founded year
2005
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Haier Biomedical manufactures IoT-enabled biomedical cold chain equipment spanning -196°C to +8°C, serving hospitals, research institutions, government health agencies, and bio-pharmaceutical companies across 135+ countries through 700+ distributors.
Ownership category
akta.pro rank

Haier Biomedical industry classification

Industry
Product category
Biomedical Cold Chain Equipment
NAICS
Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing (33341), Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use (334512), Analytical Laboratory Instrument Manufacturing (334516), Refrigerated Warehousing and Storage (493120), Medical Equipment and Supplies Manufacturing (3391)
SIC
Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip (3585), Refrigeration & Service Industry Machinery (3580), Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro primary industry
Cold Chain & Temperature-Controlled Storage Equipment (IMAHAKAJ)

Keywords

  • Biomedical cold chain
  • Ultra-low temperature freezers
  • Cryogenic storage equipment
  • IoT laboratory solutions
  • Vaccine cold chain

Where Haier Biomedical is headquartered

Location

Headquarters

HQ city
Qingdao Shi
HQ country
China
HQ region
Asia

Offices6 records

Markets served

Haier Biomedical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Cold Storage Equipment Sales: Sale of low-temperature storage equipment including ULT freezers, pharmacy refrigerators, blood bank refrigerators, cryogenics, transport coolers, and laboratory equipment covering -196°C to +8°C range.
  2. Digital IoT Solutions: IoT-enabled digital scenario solutions including U-Biobank, U-Vaccine, U-Reagent, U-Blood, and U-Laboratory networks providing comprehensive management platforms with monitoring, tracking, and automation capabilities.
  3. After-sales Service: After-sales support, maintenance, installation services, and technical support for equipment across global markets.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise equipment sales - no public pricing available

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Haier Biomedical product offering

Product offering

Core offering

Haier Biomedical manufactures and sells comprehensive cold chain equipment covering -196°C to +8°C for biomedical and life science applications, including ultra-low temperature freezers, pharmacy refrigerators, blood bank refrigerators, cryogenic liquid nitrogen storage, transport coolers, centrifuges, and laboratory equipment. The product portfolio is extended by IoT-enabled digital scenario solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) that connect hardware to cloud platforms for real-time monitoring, sample tracking, and automated management. Target customers include hospitals, bio-pharmaceutical enterprises, universities, research institutions, government health agencies, and blood stations globally.

Product overview

Haier Biomedical is a comprehensive cold chain manufacturer covering temperatures from -196°C to +8°C. The company offers a unified portfolio of products organized into Cold Storage (ULT Freezers, Pharmacy Refrigerators, Biomedical Freezers, Cryogenics, Transport Coolers), Cell Culture Solutions (CO2 Incubators, Biological Safety Cabinets, Clean Benches, Sterilization), Centrifugation equipment, Pharmacy solutions (Refrigerators, RFID Systems, Intelligent Automation), Blood Management products, Healthcare/Medical equipment, Sample Preparation tools, and Analytical Instruments. The portfolio is complemented by five IoT network solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) that connect hardware products to cloud platforms for real-time monitoring and data management. The product ecosystem spans from standalone equipment to integrated smart solutions, addressing hospitals, biobanks, pharmaceutical enterprises, research institutions, and public health organizations globally.

Differentiator

Problem solved

Functional benefit

Brands

  • U-Biobank Network: IoT-based biobank solution platform combining cryogenic storage and IoT management system for biological sample management
  • U-Vaccine Network
  • U-Reagent Network
  • U-Blood Network
  • U-Laboratory Network
  • Salvum Series
  • LX-60T100R

Products and services

  • ULT Freezers (-80°C)

Quantifiable outcome

  • Access time reduced from one minute to one second with IoT biobank management
  • +3 more outcomes

Companies that use Haier Biomedical

Customer profile

Named customers16 records

Segments6 records

Ideal customer profiles5 records

Haier Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Haier Biomedical partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered strategic and core.

  • AbcellerastrategicStrategic or Co-development Partner · 17 July 2026Partnership announced in Australia for providing cold chain solutions supporting Abcellera's biotech research and development operations.
  • World Health Organization (WHO)coreStrategic or Co-development PartnerLong-standing partnership for global health initiatives. Haier Biomedical led in WHO contract awards for Chinese suppliers and participates in WHO projects including vaccine cold chain programs in multiple countries.
  • UNICEFcoreStrategic or Co-development PartnerPartnership for global immunization programs through CCEOP (Cold Chain Equipment Optimization Platform) projects. Has supplied vaccine refrigerators to countries under UNICEF tenders.
  • UNGC (United Nations Global Compact)coreStrategic or Co-development PartnerJoined UNGC Global Initiative, committing to sustainable development principles.
  • 40+ International OrganizationscoreStrategic or Co-development PartnerPartnerships with over 40 international organizations for global health initiatives, including organizations beyond WHO and UNICEF for various healthcare and research programs.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Haier Biomedical competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific: Global life sciences tools leader with broad ULT freezer, lab equipment, and cold chain offerings (e.g., Thermo Scientific TSX, HERAfreeze). Direct overlap with Haier Biomedical in ULT freezers, pharmacy refrigeration, and CO2 incubators, but as part of a much wider instruments and consumables portfolio.
  • Trane Technologies: Global HVAC and commercial refrigeration leader. Overlaps with Haier in cold room/walk-in refrigeration and commercial cooling equipment for medical warehouses, though as part of a broader industrial HVAC portfolio.
  • Bio-Techne: Life sciences tools and reagents company with adjacent lab consumables, sample preparation, and GMP-grade proteins. Comparable customer base of pharma, biotech, and academic researchers, though not a direct cold chain competitor.
  • Dometic Group: Swedish-listed specialist in refrigeration solutions for medical, transport, and hospitality segments. Comparable in transport coolers and mobile medical refrigeration, though with broader non-biomedical focus.

Direct peers

  • PHC Holdings (PHCbi): Japan-based PHCbi brand is one of the most direct competitors to Haier Biomedical, specializing in ULT freezers, pharmacy refrigerators, and biomedical cold storage for pharma and life sciences. Competes head-to-head across the same -80°C to +8°C temperature range.
  • Helmer Scientific: US-based specialist in blood bank refrigerators, plasma freezers, and pharmacy refrigeration. Closely comparable to Haier's Blood Management product line serving hospitals and blood centers with temperature-controlled medical storage.
  • B Medical Systems: Luxembourg-based specialist in vaccine cold chain (Solar Direct Drive refrigerators, ice-lined units) and blood bank refrigeration. Direct peer in WHO PQS-certified vaccine storage solutions and a frequent competitor for UNICEF/CCEOP tenders.
  • Arctiko: Danish manufacturer of ultra-low temperature freezers, laboratory freezers, and biomedical cold storage. Comparable specialty focus on biomedical ULT and blood bank refrigeration, competing for the same European and global research/hospital customers.
  • Eppendorf: German manufacturer of laboratory equipment including ULT freezers (CryoCube), centrifuges, CO2 incubators, and consumables. Highly comparable product portfolio targeting the same hospital, pharma, and academic research customers as Haier Biomedical.

Emerging players

  • Stirling Ultracold: US-based specialist in Stirling-engine ULT freezers offering portable and energy-efficient -86°C storage. Competes in the same ULT freezer category as Haier's UltraEco and Stirling Compact ULT lines, particularly on energy efficiency.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Haier Biomedical social profiles

Digital presence

Haier Biomedical compliance and trust

Trust signal

Compliance16 records

Haier Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Haier Biomedical leadership team

Management profile

Number of profiles

Profiles11 records

Haier Biomedical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Haier Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haier Biomedical

What does Haier Biomedical do?

Haier Biomedical manufactures and sells comprehensive cold chain equipment covering -196°C to +8°C for biomedical and life science applications, including ultra-low temperature freezers, pharmacy refrigerators, blood bank refrigerators, cryogenic liquid nitrogen storage, transport coolers, centrifuges, and laboratory equipment. The product portfolio is extended by IoT-enabled digital scenario solutions (U-Biobank, U-Vaccine, U-Reagent, U-Blood, U-Laboratory) that connect hardware to cloud platforms for real-time monitoring, sample tracking, and automated management. Target customers include hospitals, bio-pharmaceutical enterprises, universities, research institutions, government health agencies, and blood stations globally.

Is Haier Biomedical a public or private company?

Haier Biomedical is a public company. It is classified as public and is currently operating.

When was Haier Biomedical founded?

Haier Biomedical was founded in 2005. It employs 5,001 to 10,000 people.

Where is Haier Biomedical based?

Haier Biomedical is headquartered in Qingdao Shi, China, in the Asia region.

How does Haier Biomedical make money?

Three revenue lines are on record. Cold Storage Equipment Sales are the primary driver. The others are digital IoT Solutions and after-sales Service.

Who are Haier Biomedical's main competitors?

Broad incumbents on record are Thermo Fisher Scientific, Trane Technologies, Bio-Techne and Dometic Group. Direct peers are PHC Holdings (PHCbi), Helmer Scientific, B Medical Systems, Arctiko and Eppendorf. Stirling Ultracold is listed as an emerging player.

Does Haier Biomedical have an API?

No public API is recorded for Haier Biomedical.

What industry is Haier Biomedical in?

Haier Biomedical's product category is Biomedical Cold Chain Equipment. Its primary akta.pro industry code is IMAHAKAJ, Cold Chain & Temperature-Controlled Storage Equipment. Its NAICS code is 33341 and its SIC code is 3585.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsLaboratory Freezers Market Projected to Hit $5.11 Billion by 2031The global laboratory freezers market is projected to grow from $4.32 billion in 2026 to $5.11 billion by 2031, representing a 3.5% compound annual growth rate, driven by increasing demand for temperature-sensitive storage solutions for vaccines, biologics, and diagnostic samples. The Asia Pacific region is expected to witness the highest growth rate at 4.2%, supported by rising investments in healthcare infrastructure and biotechnology research, while North America holds a significant market share due to its robust biomedical research infrastructure. Key players including Thermo Fisher Scientific, Haier Biomedical, and Eppendorf AG are pioneering innovations in cold storage solutions, with the cryopreservation systems segment projected to see the highest growth rate at 5.4%.MorningstarHaier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution PartnerHaier Biomedical presented its digital blood management platform at ISBT Congress 2026 in Kuala Lumpur, showcasing IoT-powered solutions for plasma collection centers, hospitals, and blood banks. The company highlighted RFID-enabled refrigerators deployed in Italy, Brazil, and the Philippines, enabling full digital tracking and reducing retrieval times to under one minute. It also cited U-Blood lot solutions operational across dozens of countries.PR NewswireGlobal Answer Sheet for Technological Inclusiveness: Haier Builds a Sustainable Ecosystem in Developing CountriesHaier Group, through its subsidiary Haier Biomedical, has implemented sustainable development initiatives across multiple developing countries, including a Solar Public Health Project in Ethiopia that has delivered over 10,000 solar-powered vaccine refrigerators and built 16 cold storage facilities covering more than 100 health stations. The company has invested USD 160 million in Egypt's Eco-Park and established Southeast Asia's first 5G-connected factory in Thailand's Chonburi Air Conditioner Industrial Park, advancing intelligent manufacturing across BRICS markets. Through its strategy of localized R&D, manufacturing, and marketing, Haier is transitioning from product trade to exporting advanced technologies including digital twin, 5G, and IoT to build sustainable industrial ecosystems in developing nations.PR NewswireBiomedical Refrigerators and Freezers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2026Reportbuyer published a global industry analysis report on the biomedical refrigerators and freezers market, covering the period from 2016 to 2026. The study outlines market drivers, restraints, opportunities, and competitive landscapes for major players including Thermo Fisher Scientific, Haier Biomedical, and Panasonic Healthcare.